Tytuł pozycji:
Oncogenic activation of JAK3-STAT signaling confers clinical sensitivity to PRN371, a novel selective and potent JAK3 inhibitor, in natural killer/T-cell lymphoma
-
Tytuł:
-
Oncogenic activation of JAK3-STAT signaling confers clinical sensitivity to PRN371, a novel selective and potent JAK3 inhibitor, in natural killer/T-cell lymphoma
-
Autorzy:
-
Nairismägi, M. -L.
Gerritsen, M. E.
Li, Z. M.Aff3, Aff4
Wijaya, G. C.Aff3, Aff4
Chia, B. K. H.
Laurensia, Y.
Lim, J. Q.
Yeoh, K. W.
Yao, X. S.Aff3, Aff4
Pang, W. L.
Bisconte, A.
Hill, R. J.
Bradshaw, J. M.
Huang, D.
Song, T. L. L.
Ng, C. C. Y.Aff3, Aff4
Rajasegaran, V.Aff3, Aff4
Tang, T.
Tang, Q. Q.Aff3, Aff4
Xia, X. J.
Kang, T. B.
Teh, B. T.Aff3, Aff4, Aff8
Lim, S. T.Aff1, Aff6, Aff9
Ong, C. K.Aff1, Aff10
Tan, J.Aff3, Aff7
-
Źródło:
-
Leukemia. 32(5):1147-1156
-
